Antibody News and Research RSS Feed - Antibody News and Research

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.
Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab). [More]
Research findings suggest efficacy of conventional flu vaccines can be improved

Research findings suggest efficacy of conventional flu vaccines can be improved

A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved. [More]
NIH researchers identify antibody that potently neutralizes 98% of HIV strains

NIH researchers identify antibody that potently neutralizes 98% of HIV strains

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class. [More]
Photoimmunotherapy may be promising treatment option to combat cancer

Photoimmunotherapy may be promising treatment option to combat cancer

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel. [More]
Researchers identify new biomarker in spinal fluid and blood serum of patients with neurological disorder

Researchers identify new biomarker in spinal fluid and blood serum of patients with neurological disorder

Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients. [More]
Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers. [More]
New Australian research shows how immune system avoids attacking own tissues with antibodies

New Australian research shows how immune system avoids attacking own tissues with antibodies

New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders. [More]
New research shows how synthetic DNA vaccine approach protects against Zika virus infection

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission. [More]
Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research. [More]
Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV, according to two related studies from Perelman School of Medicine at the University of Pennsylvania, the University of Alabama at Birmingham, and the National Institutes of Health. [More]
Novel purification process for camelid heavy chain antibodies

Novel purification process for camelid heavy chain antibodies

KNAUER Wissenschaftliche Geräte GmbH and 3B Pharmaceuticals GmbH today announced the successful completion of a federal grant program exploiting the potential of camelid antibodies. [More]
Marker found on aggressive prostate cancer cells could help guide treatments, new research shows

Marker found on aggressive prostate cancer cells could help guide treatments, new research shows

RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool. [More]
New research explains how tumors may impair ability of the liver to respond to caloric deprivation

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs. [More]
Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists at Duke Health and Zhejiang Chinese Medical University have developed a strategy to stop the uncontrollable itch caused by urushiol, the oily sap common to poison ivy, poison sumac, poison oak and even mango trees. [More]
Researchers discover antibody that can protect fetus from Zika virus in pregnant mice

Researchers discover antibody that can protect fetus from Zika virus in pregnant mice

The most devastating consequence of Zika virus infection is the development of microcephaly, or an abnormally small head, in babies who were infected in utero. [More]
Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients -- receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines. [More]
FDA approves new combo treatment for patients with advanced sarcomas

FDA approves new combo treatment for patients with advanced sarcomas

There are approximately 15,000 sarcoma cases annually in the United States, comprising more than 60 types of soft tissue sarcomas and 20 types of bony sarcomas. [More]
FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis. [More]
Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Combination therapy utilizing two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response. [More]
Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

The major challenge facing physicians treating Alzheimer's is the ability to detect markers of the disease as early as possible. These markers, located in the brain, are difficult to access, hampering diagnosis. [More]
Advertisement
Advertisement